![]() Celcuity Celcuity is a clinical-stage biotechnology company developing integrated companion diagnostic and therapeutic strategies using its proprietary functional cellular analysis platform. | Diatech Pharmacogenetics Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. | ![]() Oxford Cancer Biomarkers Oxford Cancer Biomarkers (OCB) is a company that develops and commercializes biomarker tests. | ![]() Oncomatryx Oncomatryx Biopharma is a biopharmaceutical company focused on the tumor microenvironment. | ||
Founding Date | Founding Date 2012 | Founding Date 1997 | Founding Date 1994 | Founding Date 2012 | Founding Date 2009 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Minneapolis, US HQ | Locations Lund, SE HQ | Locations Jesi, IT HQ | Locations Kilmacolm, GB HQ | Locations HQ |
Employees | Employees 3011% increase | Employees 118 | Employees 751% increase | Employees 713% decrease | Employees 274% increase |
Valuation ($) | Valuation ($) 589.2 m | Valuation ($) 285.9 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($177m) (FY, 2025) | Net income (kr332.9m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 1.9m (almost 11 years ago) | Latest funding round N/A | Latest funding round $ 4.9m (over 10 years ago) |
Total funding raised | Total funding raised $ 14.5m | Total funding raised N/A | Total funding raised $ 1.9m | Total funding raised N/A | Total funding raised $ 4.9m |

BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View companyDiatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine.
View company
Oxford Cancer Biomarkers (OCB) is a company that develops and commercializes biomarker tests.
View company
Oncomatryx Biopharma is a biopharmaceutical company focused on the tumor microenvironment.
View company